Predictive Oncology Inc. (POAI) Stock Overview
Explore Predictive Oncology Inc.’s financial performance, market position, analyst ratings, and future outlook.
Predictive Oncology Inc. (POAI)
Key Financials
Key Financials
Market Cap
3.6M
P/E Ratio
-0.03
EPS (TTM)
$-141.32
ROE
-107.05%
POAI Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Predictive Oncology Inc. (NASDAQ: POAI) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Predictive Oncology Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of POAI on the NASDAQ shows an RSI of 32.90, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $6.47 for the NASDAQ listing.
Key metrics behind Predictive Oncology Inc.'s NASDAQ-traded stock include a P/E ratio of -0.03 and a market capitalization of 3.6M. Combined with our AI analysis, these give both institutional and retail investors a clear view of POAI on the NASDAQ.